Anonymous
Guest
Anonymous
Guest
U hit the nail on the head! It's not enough for a tenured rep especially in medical device! Target comp isn't terrible but the big elephant in the room that no one ever brings up is the reality will be much lower. You can possibly hit your number for multiple buckets year in year out.
I know the turnover is increasing. There have been some people that left where I thought wow, Ethicon lost a hell of a rep and likely did nothing to try to retain them. U gotta pay to play, and it's obvious corporate just doesn't want to play
Well someone has to make up for the $2.2 billion for Risperdal, 22,000+ mesh cases and pending $3 billion hips-you're not going to see Gorsky or Pruden's bonus cut but they'll make the reps take.